Connect with us

Company News

Zydus Receives Tentative Approval for Linagliptin and Metformin Hydrochloride Tablets

Zydus Cadila has received the tentative approval from the USFDA to market Linagliptin and Metformin Hydrochloride Tablets (US RLD – Jentadueto Tablets), 2.5 mg/500 mg, 2.5 mg/850 mg and 2.5 mg/1,000 mg. It will be manufactured at the group’s formulations manufacturing facility at SEZ, Ahmedabad. It is used along with diet and exercise to improve control of blood sugar levels in adults with type 2 diabetes mellitus. The group now has 221 approvals and has so far filed over 330 ANDAs since the commencement of the filing process in FY 2003-04. – Medical Buyer Bureau

Copyright © 2024 Medical Buyer

error: Content is protected !!